BONE MINERAL DENSITY IN PATIENTS WITH SKELETAL DYSPLASIAS
BONE MINERAL DENSITY IN PATIENTS WITH SKELETAL DYSPLASIAS
批准号:
8166669
负责人:
Brendan Lee
金额:
$0.34万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-11-30
关键词:
AffectAgeBone DensityCartilageComputer Retrieval of Information on Scientific Projects DatabaseCross-Sectional StudiesDataDepositionDiseaseDual-Energy X-Ray AbsorptiometryFundingGenderGene MutationGeneral PopulationGoalsGrantGrowthGrowth and Development functionInstitutionInterventionKnowledgeMeasurementMineralsNatural HistoryPatientsPilot ProjectsProspective StudiesProtocols documentationResearchResearch PersonnelResourcesRiskScanningShapesSkeletonSourceUnited States National Institutes of Healthbone massbone strengthchondrodysplasiadensitydesignpatient populationskeletal dysplasia
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得主要资金,
因此可以在其他CRISP条目中表示。列出的机构是
中心,不一定是研究者的机构。
本研究的总体目标是检查骨骼发育不良患者与相似年龄的普通人群相比,骨密度是否发生变化。 骨骼发育不良是一组异质性疾病,其特征在于骨骼的生长和发育异常。 包括与骨强度和完整性的主要改变相关的骨发育不良,以及影响软骨的软骨发育不良,从而影响骨骼的形状和纵向生长。 由于没有描述该患者人群骨密度的初步数据,因此建议将其作为初探性研究。 将使用双能X线吸收测定法(DXA扫描)以可靠的方式测量这些受试者的骨量密度。 对结果的分析将使我们能够设计进一步的研究方案,以建立基因突变和矿物质沉积改变之间的相关性。 此外,这些数据将为旨在确定不同干预措施对这些患者管理的影响的前瞻性研究提供基线。
我们的一般假设是,与年龄和性别相似的普通人群相比,骨骼发育不良患者的骨密度可能会发生变化。
本研究的目的是确定骨骼发育不良患者的骨密度与年龄和性别相似的普通人群是否存在差异。 这些知识将使我们能够进一步描述这些疾病的自然史,并确定那些有骨密度降低风险的患者,以便提供有效,及时的治疗。
由于没有描述该患者人群骨密度的初步数据,因此建议将其作为一项先导性横断面研究。 对结果的分析还将使我们能够设计进一步的研究方案,研究包括骨骼发育不良在内的不同疾病中的骨密度问题,并建立基因突变与矿物质沉积改变之间的相关性。 此外,这些数据将为旨在确定不同干预措施对这些患者管理的影响的前瞻性研究提供基线。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The overall goal of this study is to examine whether patients with skeletal dysplasias have alterations in bone mineral density when compared to the general population of similar age. Skeletal dysplasias are a heterogeneous group of disorders characterized by abnormalities in the growth and development of the skeleton. The include the osteodysplasias, associated with primary alterations of bone strength and integrity, and chondrodysplasias which affect the cartilage, and hence, the shape and longitudinal growth of the skeleton. This is proposed as a pilot study since there are no preliminary data describing bone densities in this population of patients. Measurement of the bone mass density in these subjects will be performed in a reliable way using dual-energy X-ray absorptiometry (DXA scanning). Analysis of the results will allow us to design further research protocols to establish correlations between gene mutations and alterations in mineral deposition. Moreover, this data will provide a baseline for prospective studies aimed at determining the effects of different interventions for the managemnt of these patients.
Our general hypothesis is that patients with skeletal dysplasias may have alterations in bone mineral density when compared to the general population of similar age and gender.
The purpose of this study is to determine whether patients with skeletal dysplasias have differences in bone mineral density from the general population of similar age and gender. This knowledge will enable us to further delineate the natural histories of these conditions, and to identify those patients at risk for decreased bone mineral density so that effective, timely treatment may be offered.
This is proposed as a pilot, cross sectional study since there are no preliminary data describing bone densities in this population of patients. Analysis of the results will also allow us to design further research protocols looking at the issue of bone density in the different diseases that comprise skeletal dysplasias, and to establish correlations between gene mutations and alterations in mineral deposition. Moreover, this data will provide a baseline for prospective studies aimed at determining the effects of different interventions for the management of these patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting TGFb In Osteogenesis Imperfecta
-
批准号:10736736
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2023
-
负责人:Brendan Lee
-
依托单位:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
-
批准号:10528208
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2022
-
负责人:Brendan Lee
-
依托单位:
Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta
-
批准号:10665057
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2022
-
负责人:Brendan Lee
-
依托单位:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
-
批准号:10307410
-
项目类别:
-
资助金额:$108.91万
-
财政年份:2021
-
负责人:Brendan Lee
-
依托单位:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
-
批准号:10663584
-
项目类别:
-
资助金额:$167.55万
-
财政年份:2021
-
负责人:Brendan Lee
-
依托单位:
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues
-
批准号:10316864
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2021
-
负责人:Brendan Lee
-
依托单位:
ALL OF US EVENINGS WITH GENETICS RESEARCH EDUCATION PROGRAM
-
批准号:10804507
-
项目类别:
-
资助金额:$167.55万
-
财政年份:2021
-
负责人:Brendan Lee
-
依托单位:
WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues
-
批准号:10684863
-
项目类别:
-
资助金额:$57.6万
-
财政年份:2021
-
负责人:Brendan Lee
-
依托单位:
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency
-
批准号:9329788
-
项目类别:
-
资助金额:$40.3万
-
财政年份:2017
-
负责人:Brendan Lee
-
依托单位:
Nitric Oxide and Bone Homeostasis in Patients with Argininosuccinate Lyase Deficiency
-
批准号:9896758
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2017
-
负责人:Brendan Lee
-
依托单位:
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
-
批准号:10392597
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
-
批准号:10515367
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
ADMIN CORE
-
批准号:10254385
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
-
批准号:10267291
-
项目类别:
-
资助金额:$23.29万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
-
批准号:10478155
-
项目类别:
-
资助金额:$143.86万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
PROJECT 2: INVISALIGN TRIAL
-
批准号:10478161
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network
-
批准号:8765079
-
项目类别:
-
资助金额:$125.81万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
-
批准号:10707042
-
项目类别:
-
资助金额:$138.91万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
PILOT-FEASIBILITY
-
批准号:10707051
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
Argininosuccinate lyase is an essential regulator of systemic nitric oxide produc
-
批准号:9320990
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2014
-
负责人:Brendan Lee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: